Congenital hypopituitarism in two brothers with a duplication of the 'acrogigantism gene' GPR101: clinical findings and review of the literature
Open Access
- 1 April 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Pituitary
- Vol. 24 (2), 229-241
- https://doi.org/10.1007/s11102-020-01101-8
Abstract
Purpose Congenital hypopituitarism (CH) can cause significant morbidity or even mortality. In the majority of patients, the etiology of CH is unknown. Understanding the etiology of CH is important for anticipation of clinical problems and for genetic counselling. Our previous studies showed that only a small proportion of cases have mutations in the known 'CH genes'. In the current project, we present the results of SNP array based copy number variant analysis in a family with unexplained congenital hypopituitarism. Methods DNA samples of two affected brothers with idiopathic CH and their mother were simultaneously analyzed by SNP arrays for copy number variant analysis and Whole Exome Sequencing (WES) for mutation screening. DNA of the father was not available. Results We found a 6 Mb duplication including GPR101 and SOX3 on the X-chromosome (Xq26.2-q27.1) in the two siblings and their mother, leading to 2 copies of this region in the affected boys and 3 copies in the mother. Duplications of GPR101 are associated with X-linked acrogigantism (the phenotypic 'opposite' of the affected brothers), whereas alterations in SOX3 are associated with X-linked hypopituitarism. Conclusion In our patients with hypopituitarism we found a 6 Mb duplication which includes GPR101, a gene associated with X- linked gigantism, and SOX3, a gene involved in early pituitary organogenesis that is associated with variable degrees of hypopituitarism. Our findings show that in duplications containing both GPR101 and SOX3, the growth hormone deficiency phenotype is dominant. This suggests that, if GPR101 is duplicated, it might not be expressed phenotypically when early patterning of the embryonic pituitary is affected due to SOX3 duplication. These results, together with the review of the literature, shed a new light on the role of GPR101 and SOX3 in pituitary function.Funding Information
- Pfizer Pharmaceuticals
- University Medical Center Rotterdam
This publication has 52 references indexed in Scilit:
- Identification of SOX3 as an XX male sex reversal gene in mice and humansJCI Insight, 2011
- X-linked isolated growth hormone deficiency: expanding the phenotypic spectrum of SOX3 polyalanine tract expansionsClinical Dysmorphology, 2009
- Anatomical Profiling of G Protein-Coupled Receptor ExpressionCell, 2008
- Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factorsThe International Journal of Biochemistry & Cell Biology, 2007
- Duplication of Xq26.2-q27.1, includingSOX3, in a mother and daughter with short stature and dyslaliaAmerican Journal of Medical Genetics Part A, 2005
- Over- and Underdosage of SOX3 Is Associated with Infundibular Hypoplasia and HypopituitarismAmerican Journal of Human Genetics, 2005
- Increased Gene Dosage at Xq26–q27 Is Associated with X-Linked HypopituitarismGenomics, 2002
- Identification and Characterization of an Xq26–q27 Duplication in a Family with Spina Bifida and Panhypopituitarism Suggests the Involvement of Two Distinct GenesGenomics, 2000
- X-linked mental retardation with isolated growth hormone deficiency is mapped to Xq22-Xq27.2 in one familyAmerican Journal of Medical Genetics, 1998
- Familial X-linked mental retardation and isolated growth hormone deficiency: Clinical and molecular findingsAmerican Journal of Medical Genetics, 1996